×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [18]
昆明植物研究所 [3]
合肥物质科学研究院 [3]
过程工程研究所 [2]
青岛生物能源与过程研... [2]
兰州理工大学 [1]
更多...
内容类型
期刊论文 [33]
学位论文 [1]
发表日期
2018 [34]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共34条,第1-10条
帮助
限定条件
发表日期:2018
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 28, 期号: 23-24, 页码: 3693-3699
作者:
Zhu, Kongkai
;
Song, Jia-Li
;
Tao, Hong-Rui
;
Cheng, Zhi-Qiang
;
Jiang, Cheng-Shi
收藏
  |  
浏览/下载:102/0
  |  
提交时间:2019/01/08
Pharmacophore combination
Isoquinoline
PRMT5 inhibitor
Molecular docking
Molecular dynamics simulation
Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 卷号: 26, 期号: 22, 页码: 5780-5791
作者:
Guo, Bin
;
Guo, Shimeng
;
Huang, Jing
;
Li, Jingya
;
Li, Jia
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2019/01/08
GPR40 agonist
2,3-Dihydrobenzo[b][1,4]dioxine
Insulin secretion
Type 2 diabetes mellitus
Design, Synthesis, and SAR Studies of Heteroarylpyrimidines and Heteroaryltriazines as CB2R Ligands
期刊论文
CHEMMEDCHEM, 2018, 卷号: 13, 期号: 22, 页码: 2455-2463
作者:
Qian, Hai-Yan
;
Wang, Zhi-Long
;
Chen, Li-Li
;
Pan, You-Lu
;
Xie, Xiao-Yu
收藏
  |  
浏览/下载:92/0
  |  
提交时间:2019/01/08
cannabinoids
CB1R
CB2R
heteroaryl pyrimidines
heteroaryl triazines
ligands
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma
期刊论文
ONCOGENESIS, 2018, 卷号: 7
作者:
Chen, Wei
;
Zhang, Hao
;
Chen, Zhifeng
;
Jiang, Hao
;
Liao, Liping
收藏
  |  
浏览/下载:109/0
  |  
提交时间:2019/01/08
Enhancement of isobutane/butene alkylation by aromatic-compound additives in strong Bronsted acid
期刊论文
FUEL, 2018, 卷号: 231, 页码: 224-233
作者:
Zhang, Honghua
;
Tang, Hongguo
;
Xu, Jiakuo
;
Li, Yajing
;
Yang, Zhiqiang
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2018/07/18
Aromatic-compound Additives
Sulfuricacid
Isobutane/butene Alkylation
Trimethylpentane
Selectivity
Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino) cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl) tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 158, 页码: 896-916
作者:
Wang, Beilei
;
Wu, Jiaxin
;
Wu, Yun
;
Chen, Cheng
;
Zou, Fengming
收藏
  |  
浏览/下载:68/0
  |  
提交时间:2019/12/25
CDK9
Kinase inhibitor
Structure-activity relationship
Leukemia
Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 28, 期号: 15, 页码: 2599-2604
作者:
Sheng, Ren
;
Yang, Liu
;
Zhang, Yanchun
;
Xing, Enming
;
Shi, Rui
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/01/08
GPR120
Agonist biphenyl derivatives
OGTT
Type 2 diabetes
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3K delta) inhibitor
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 156, 页码: 831-846
作者:
Liang, Xiaofei
;
Li, Feng
;
Chen, Cheng
;
Jiang, Zongru
;
Wang, Aoli
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/10
PI3K delta
Kinase inhibitor
Acute myeloid leukemia
Structure-activity relationship
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 卷号: 26, 期号: 12, 页码: 3559-3572
作者:
Qin, Li-Huai
;
Wang, Zhi-Long
;
Xie, Xin
;
Long, Ya-Qiu
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/01/08
6,7,8,9-Tetrahydro-5H-pyrido[43-c]azepin-5-one
3,4-Dihydro-2,6-naphthyridin-1(2H)-one
CCR2 antagonist
Scaffold hopping
Structure-activity relationship
Selectivity of CCR2 over CCR5
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 13, 页码: 5609-5622
作者:
Hao, Yongjia
;
Lyu, Jiankun
;
Qu, Rong
;
Tong, Yi
;
Sun, Deheng
收藏
  |  
浏览/下载:64/0
  |  
提交时间:2019/01/08
©版权所有 ©2017 CSpace - Powered by
CSpace